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Abstract
Maternal diabetes impairs fetal development and increases the risk of metabolic
diseases in the offspring. Previously, we showed maternal dietary supplementation with
6% of olive oil prevents diabetes-induced embryo and fetal defects, in part, through
the activation of peroxisome proliferator-activated receptors (PPARs). In this study,
we examined the effects of this diet on neonatal and adult pancreatic development
in male and female offspring of mothers affected with pre-gestational diabetes. A
mild diabetic model was developed by injecting neonatal rats with streptozotocin (90
mg/kg). During pregnancy, these dams were fed a chow diet supplemented or not
with 6% olive oil. Offspring pancreata was examined at day 2 and 5 months of age
by immunohistochemistry followed by morphometric analysis to determine number
of islets, α and β cell clusters and β-cell mass. At 5 months, male offspring of diabetic
mothers had reduced β-cell mass that was prevented by maternal supplementation with
olive oil. PPAR-α and PPAR-γ were localized mainly in α cells and PPARβ/δ in both α and
β cells. Although PPARβ/δ and PPARγ RNA expression showed reduction in 5-monthold male offspring of diabetic rats, PPAR β/δ expression returned to control levels after
olive-oil supplementation. Interestingly, in vitro exposure to oleic acid (major component
of olive oil) and natural PPAR agonists such as LTB4, CPC and 15dPGJ2 also significantly
increased expression of all PPARs in αTC1–6 cells. However, only oleic acid and 15dPGJ2
increased insulin and Pdx-1 expression in INS-1E cells suggesting a protective role in
β-cells. Olive oil may be considered a dietary supplement to improve islet function in
offspring of affected mothers with pre-gestational diabetes.
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Introduction
Q5

The in utero environment plays an important role in
the development of the fetus and the neonate (Harris
et al. 2017, Marciniak et al. 2017). Pre-gestational
diabetes affects organogenesis and increases the risk of
congenital malformations (Correa et al. 2008). Moreover,
both pre-gestational and gestational diabetes raise the
https://joe.bioscientifica.com
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predisposition to insulin resistance early in life (Catalano
et al. 2003, Lacroix et al. 2013) and the development of
type 2 diabetes (Sobngwi et al. 2003, Chon et al. 2014).
In humans, exposure to hyperglycemia in utero leads to
differential effects on male and female offspring upon
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the risk of developing diabetes later in life (Sobngwi et al.
2003, Mauvais-Jarvis 2018).
It has been shown that not only the quantity (Ojha
et al. 2013), but the quality and ratio of components of
the maternal diet also affects both fetal and postnatal
development (Herring et al. 2018). Importantly, lipids
play a role in fetal development and variations to dietary
fat composition has major implications, both short- and
long-term, on offspring health (Herrera 2002, Berti et al.
2016). For example, oleic acid, a monounsaturated fatty
acid (MUFA) given in pregnancy to diabetic rats lowers
phospholipids, cholesterol and free fatty acid content
in foetuses (Capobianco et al. 2008a). Furthermore, in
humans, the addition of olive oil to the diet in individuals
with type 2 diabetes has beneficial effects on blood glucose
and reducing insulin resistance (Ryan 2000).
Previous research from our group has indicated
that an enriched olive-oil diet given during gestation to
mothers with mild diabetes improves fetal and placental
development (Capobianco et al. 2008a; Martinez
et al. 2012, Kurtz et al. 2014a), mainly by reducing the
intrauterine inflammatory environment and regulating
lipid metabolic pathways such as fatty acid uptake, lipid
synthesis and catabolism (Jawerbaum & Capobianco
2011). Furthermore, these beneficial effects were
identified to be mediated, in part, by the activation
of the entire nuclear peroxisome proliferator-receptor
(PPAR) family, namely PPARα, PPAR β/δ and/or PPARγ.
The three members of this family of nuclear receptors are
involved in feto-placental development, cell proliferation,
differentiation, and metabolism (carbohydrate, lipid,
protein) (Rees et al. 2008). Nevertheless, PPARs represent
critical sensors of environmental dietary stimuli and
are crucial in the regulation of metabolism. As primary
regulators of lipid metabolism at the cellular level, they
help maintain metabolic homeostasis when energy or
lipid dietary composition is altered (Bordoni et al. 2006).
In maternal diabetes, PPARs levels and transcriptional
activity are impaired in the placenta and different fetal
organs, with further influence on the postnatal stage (i.e.
the fetal origins of metabolic diseases) (Rees et al. 2008,
Jawerbaum & Capobianco 2011, Jawerbaum & White
2017). PPARs function as critical transcription factors
when activated by unsaturated fatty acids, which are
efficiently transported through the placenta to the uterus
(Herrera 2002, Bordoni et al. 2006). Furthermore, dietary
supplements enriched in 6% olive oil or safflower oil
during diabetic pregnancies have been shown to activate
PPARs, leading to the prevention of the metabolic and
pro-inflammatory impairments in the fetus with evident
https://joe.bioscientifica.com
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results in the offspring, including the increase in insulin
secretion (Capobianco et al. 2008a, 2015, Higa et al. 2010).
While PPARs are ubiquitous in the pancreas during
normal embryonic development (Braissant & Wahli 1998)
and play an important role in pancreatic glucose and lipid
metabolism, the role of in utero pancreatic PPAR activation
remains elusive.
A previous report has indicated that oleic acid (the
major component of olive oil), a natural activating ligand
of PPARs, exhibits anti-diabetic and anti-inflammatory
properties in the INS-1E pancreatic cell line (Ravnskjaer
et al. 2010). A rat model of maternal mild diabetes is useful
to study the programming of the pancreatic development
and the putative beneficial effects of the intervention
with a normolipidemic diet enriched in oleic acid.
Therefore, we hypothesize that olive-oil supplementation
during pregnancy to a mild pre-gestational diabetic rat
will activate PPARs in utero and might benefit the pancreas
of the offspring postnatally.

Materials and methods
Animals
The in vivo experiments followed the Principles of
Laboratory Animals Care (NIH publication number
85-23, revised 1985, http://grants!.nih.gov/grants/
olaw/ references/phspol.htm) and were approved by
the Institutional Committee for the Care and Use of
Experimental Animals (CICUAL, Resolution CD Nº
3170/2015; School of Medicine, UBA, Argentina). Eight
male and sixteen female adult Albino Wistar rats were
purchased from the certified animal facilities of the School
of Exact and Natural Sciences, University of Buenos Aires
(UBA, Argentina). The rats were housed in the animal
facilities of the Center for Pharmacological and Botanical
Studies (CEFYBO-UBA-CONICET, Argentina) on a 12 h
light:12 h darkness cycle with humidity maintained at
a 45–60% and temperature between 21 ± 2°C. The rats
had ad libitum access to food and water throughout the
study. For mating the female rats, two females were placed
in one cage with a male and mating was confirmed by
the presence of spermatozoa in the vaginal smear the
following morning. Two days after birth, female neonates
from each rat were randomly selected to rendered
diabetic by a s.c. injection of streptozotocin (90 mg/kg,
Sigma-Aldrich) diluted in citrate buffer (0.05 M, pH 4.5,
Sigma-Aldrich), as described before (Kurtz et al. 2010),
or received citrate buffer alone (controls). The health of
the rats and the environmental parameters were checked
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and recorded daily. At 2 months of age, prior to mating to
control males, female offspring were confirmed diabetic
by a fasting glucose reading (higher than 130 mg/dL) with
a hand-held glucometer (Accu-Check, Roche Diagnostics)
without anesthesia from lancing the tail vein. Twenty-four
female rats (8 control and 16 diabetic rats) were housed
in separate cages (two female: one male rat ratio) and
pregnancy was confirmed by the presence of spermatozoa
in vaginal smears the next morning. No adverse effects
were observed by the dietary interventions or procedures
detailed subsequently. At day 1 of pregnancy, rats were
allocated into three groups (n = 8 each). The number of
rats used was determined by statistical power analysis.
Eight control (C) and eight diabetic (D, randomly selected)
rats received a normal commercial chow diet composed
of (g/100 g): carbohydrates (50); proteins (25); fat (5),
major fatty acids 16:0 (0.58), 18:0 (0.16), 18:1 (1.27), 18:2
(1.99), 18:3 (0.73); calories: 325 kcal/100 g (Asociacion
Cooperativa Argentina, Buenos Aires, Argentina). A
third group of eight diabetic rats randomly selected were
supplemented with 6% olive oil (a supplement diet that
is 354% enriched in oleic acid, PPAR activator) (D+OO)
in the pellet. The composition of the diet was described
previously (Capobianco et al. 2015) and contains: (1.)
normal standard diet (composition listed previously) and
(2.) olive-oil-supplemented diet (g/100 g): carbohydrates
(48); proteins (24); fat (11), major fatty acids 16:0
(1.55), 18:0 (0.26), 18:1 (5.77), 18:2 (2.41), 18:3 (0.57);
calories: 340 kcal/100g. Food and water were provided
ad libitum. Food intake was similarly increased in the
diabetic group that received or not the olive-oil dietary
treatment: control: 67 ± 3 g/kg/day, maternal diabetes:
75 ± 3 g/kg/day, maternal diabetes + olive oil: 73 ± 3 g/
kg/day. Weight gain was similar in the evaluated groups
(control: 132 ± 8 g, maternal diabetes: 135 ± 9 g, maternal
diabetes + olive oil: 119 ± 10 g). Fasting glycemia values,
evaluated on day 20 of pregnancy, were similar in the
diabetic group that received or not the olive-oil dietary
treatment (control: 101 ± 10 mg/dL, maternal diabetes:
229 ± 19 mg/dL, maternal diabetes + olive oil: 208 ± 10
mg/dL). After birth, all the rats were fed with a normal
chow diet. Body weight and food intake were measured
bi-weekly. Maternal body weight was similar at weaning
in the evaluated groups (control: 315 ± 14 g, maternal
diabetes: 318 ± 12 g, maternal diabetes + olive oil: 324 ± 15
g). Offspring weight was evaluated on a per litter basis.
Each litter was weighted on day 2 of pregnancy and litter
was adjusted to three males and three females. Housing
conditions were maintained as described previously. At
postnatal day 2 and at 5 months old, two female and two
https://joe.bioscientifica.com
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male rats per litter were kiled by decapitation at 12:00 h.
Pancreata were dissected immediately and fixed in 4%
formalin or immersed in RNAlater (RNA later, Invitrogen).
Glycemia was also measured before killing by a hand-held
glucometer (Accu-Check, Roche Diagnostics) on postnatal
day 2 and after 6 h fasting at 5 months old rats from blood
obtained by lancing the tail vein.
Immunofluorescence
After a 24-h fixation in 4% buffered formalin (west-Chester,
PA, USA) pancreata were dehydrated and embedded in
paraffin (University Hospital, Pathology Lab, London, On,
Canada) and sectioned in 5-µm sections and mounted
in Superfrost-Plus slides (Fischer Scientific, Toronto, On,
Canada). In order to localize α-cells and β-cells within
the islets of Langerhans, dual immunofluorescence was
performed. Three 5-µm sections, separated by at least
50 µm, were deparaffinized in xylene, rehydrated in
descending ethanol series (100%, 90%, 70%) and washed
in tap water. Tissues were then blocked with 1–2 drops
of Sniper (Biocare Medical, California, USA) for 5 min.
All antisera were diluted in antibody diluent solution
(DakoCytomation). Tissues were then incubated overnight
at 4°C in a humidified chamber with 1:50 guinea pig antiinsulin (Abcam) and 1:750 rabbit anti-glucagon (Novus
Biologicals, Centennial, CO, USA) primary antibodies.
Slides were then rinsed and incubated for 60 min in
darkness in a humidified chamber with its correspondent
secondary antibodies (Invitrogen) 1:500 Donkey antiguinea pig (Alexa Flour 555), and 1:500 Donkey antirabbit (Alexa 488) fluorescent secondary antibodies and
DAPI (Sigma-Aldrich) was used to counterstain nuclei.
Coverslip was applied with the addition of an anti-fade
mounting solution (Life Technologies). To establish the
specificity of all antibodies, controls included substitution
of the primary antibody with non-immune serum or
omission of the secondary antibody.
To further identify the co-localization of β-cells with
the different PPARs isotypes (α, β/δ and γ) within the islets
of Langerhans, dual immunofluorescence was performed.
After deparaffinization as described previously, tissues
were treated with citrate buffer pH 6 in a decloaking
chamber for 20 min for antigen retrieval. Slides were
left to cool at room temperature, washed in PBS and
blocked with 1–2 drops of Sniper (Biocare Medical, CA,
USA) for 10 min at room temperature. All antisera were
diluted in antibody diluent solution (DakoCytomation).
Primary antibodies anti-mouse insulin (1:200) (SigmaAldrich) with anti-rabbit PPAR α (1:100) (Abcam) or anti-
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rabbit PPAR β/δ (1:50) (Santa Cruz biotechnology Inc.)
and anti-rabbit PPAR γ (1:50) (Santa Cruz biotechnology
Inc.) were incubated in a humidified chamber for 48 h at
4°C. Slides were then rinsed and incubated for 60 min in
darkness in a humidified chamber with its correspondent
secondary antibodies (Invitrogen) at a concentration of
(1:500) Donkey anti-mouse (AlexaFluor 555) and (1:500)
Donkey anti-rabbit (Alexafluor 488) at room temperature.
This was followed by two 5-min PBS washes. Nuclear
counterstain DAPI (Sigma-Aldrich, 1:500) was applied
before the addition of coverslip with anti-fade mounting
solution (Life Technologies). To establish the specificity
of all antibodies, controls included substitution of the
primary antibody with non-immune serum or omission
of the secondary antibody.

using Qiagen RNeasy Plus kit (Qiagen, Inc.) according
to the manufacturer’s specifications and stored until
further analysis. Sample yield and purity was quantified
by absorbance at 260 and 280 nm (value 1.7–2) using
NanoDrop 2000c Spectrophotometer (Thermo Fisher
Scientific). Transcript abundance for PPARα, β/δ, ϒ, insulin
and Pdx-1 was analyzed using Quantitative RT PCR
(RT-qPCR). RNA was amplified using designed primers
(Primer-BLAST A, NCBI, NIH) with a Power SYBR® Green
RNA-to-CT™ 1-Step Kit (Applied Biosystems, Thermo
Fisher Scientific) following manufacturer’s protocol.
Primer sequences are in Table 1. Relative quantification
was performed using 2−ΔΔ Ct method with β-actin as the
housekeeping gene. Data was determined as the relative
expression ratio to control samples.

Morphometric analysis

Cell culture

Analysis of pancreatic sections was performed using a
Carl Zeiss Axioskop transmitted light and fluorescent
microscope (Carl Zeiss Inc.) with QImaging Micro
Publisher 3.3 Real Time viewing camera (QImaging,
Burnaby, BC, Canada). Digital images were captured with
40× or 2.5× objectives lens. Image analysis of sections and
quantification of areas of interest was performed using
ImageJ v1.51s software (NIH) (Chamson-Reig et al. 2009).
Data processing and statistical analysis were performed
using Excel v16.12 (Microsoft) and GraphPad Prism v7.00
(GraphPad Software, Inc.).
For each analysis, five male and five female animals
per group (one male and one female per litter, a total
of 30 rats) were randomly selected. Subsequently, three
random sections (separated for at least 50 µm) from each
pancreas were analyzed. Multiple fields of view were
assessed upon the entire pancreas, to ensure all islets were
analyzed. For each section, the following measurements
were determined: total pancreatic area, islet area and total
area occupied by α and β-cells and β-cell mass in mg (total
β cell area × pancreatic weight/total pancreatic area).
Islets were separated by size, clusters (<500 µm2), small
(500–5000 µm2), medium (5000–10,000 µm2) and large
(>10,000 µm2).

To further understand the direct effects of oleic acid on
the expression profile of PPARs in the endocrine pancreas,
two different cell lines were utilized as they represent
specific endocrine cells. INS-1E cells is a β-cell line
(insulin) and αTC1–6 is an α-cell line (glucagon). INS-1E
cells were cultured in RPMI1640 supplemented with 11
mM glucose, 1 mM pyruvate, 10 mM HEPES, 100 µM
β-mercaptoethanol, 10% FBS and penicillin/streptomycin.
αTC1–6 cells were cultured in DMEM (Thermo Fisher
Scientific) supplemented with 5.5 mM glucose, 2.5% FBS
and 15% horse serum. For each cell line, 105 cells per
well were cultured in 6-well plates for 24 h. Media were
replaced with serum free media and cells were treated in
the presence or absence of 5 μM oleic acid (OA) (major
component of olive oil) (Sigma-Aldrich) (Vassiliou et al.
2009), 1 μM 15 deoxyΔ12,14 Prostaglandin J2 (15dPGJ2)
(Cayman) (Capobianco et al. 2008), 0.1 μM Leukotriene
B4 (LTB4) (Cayman) (Martínez et al. 2011) and 1 μM
Carbaprostacyclin (CPC) (Cayman) (Higa et al. 2007) for

RNA extraction and qPCR
At 5 months of age, eight female and eight male pancreata
(one male and one female per litter) per group of
treatment (a total of 48 rats) were dissected and immersed
immediately in RNAlater (Ambion, Inc.) and stored at
−80°C until RNA extraction. Total RNA was extracted
https://joe.bioscientifica.com
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Table 1
PPAR α
PPAR α
PPAR β/δ
PPAR β/δ
PPAR ϒ
PPAR ϒ
Pdx-1
Pdx-1
Insulin
Insulin
β-Actin
β-Actin

Primer sequences for q-PCR.
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse

TCCTCTGGTTGTCCCCTTGA
TGTCAGTTCACAGGGAAGGC
GCTCCTGCTCACTGACAGAT
CGTGGCCACTTCCTCTTTCT
CCTGTTGACCCAGAGCATGG
GGTCCACAGAGCTGATTCCG
CCGCGTTCATCTCCCTTTC
TGCCCACTGGCTTTTCCA
CCCGGCAGAAGCGTGGCATT
CATTGCAGAGGGGTGGGCGG
CGCGAGTACAACCTTCTTGC
ATACCCACCATCACACCCTG

Q6
Q7
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24 h. At the end of incubation, total RNA was isolated
using Qiagen total RNA isolation kit (RNeasy mini kit)
according to the supplier’s protocol. cDNA synthesis
and Real-time PCR were performed using Power SYBR®
Green RNA-to-CT™ 1-Step Kit (Thermo Fisher Scientific).
Primers specific for PPARα, PPARβ/δ and PPARγ, Pdx-1 and
insulin were used (Table 1). Relative expression levels were
determined using 2−ΔΔ Ct method.

Statistical analysis
Data were presented as mean ± s.e.m. One-way ANOVA
followed by Bonferroni post-hoc test was used to compare
all groups. In case of comparison of only two groups, we
used t-test. The differences were considered statistically
significant at P < 0.05. Statistical analysis was performed
using Graph Pad Prism Version 7 (GraphPad Inc.).

Results
Body weight, pancreas weight and fasting glycemia
To understand the general effects of maternal diabetes
and the dietary supplementation with 6% olive oil on
maternal outcomes, we measured body weight, pancreas
weight and glycemia at day 2 and 5 months on postnatal
male and female offspring. At day 2, there were no
statistical differences between body and pancreas weight
and/or glycemia within all treatment groups in both sexes
(Table 2). By 5 months of age, male and female offspring
exhibited no changes in body weight and pancreas
weight within all the groups. However, glycemia, was
significantly increased in the male and female offspring
from the diabetic dam groups, compared to the controls
(P < 0.05) (Table 3). Interestingly, the gestational dietary
treatment with olive oil in diabetic mothers prevented the
increased glycemia in the 5-month male offspring but not
the female offspring (P < 0.05 vs control group) (Table 3).

Pancreatic morphometry
To examine if alterations in pancreatic development
underlie the changes in postnatal glycemia observed, the
percentage of islet area was measured to determine the
effects of the olive-oil supplementation on the postnatal
endocrine pancreas in male and female offspring born to
diabetic mothers.
At postnatal day 2, the percentage of islet area was
statistically different in males between control and
https://joe.bioscientifica.com
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Weight and glycemia in 2-day-old female and male

offspring.

Control

Females
Body weight
6.32 ± 0.14
(g)
Pancreas
0.025 ±
weight (g)
0.003
Glycemia (mg/
64 ± 2
dL)
Males
Body weight
6.42 ± 0.20
(g)
Pancreas
0.022 ±
weight (g)
0.002
Glycemia (mg/
61 ± 3
dL)

Maternal
diabetes

Maternal
diabetes + olive
oil

6.32 ± 0.15

6.60 ± 0.12

0.027 ± 0.001

0.024 ± 0.001

69 ± 5

70 ± 3

6.60 ± 0.16

6.20 ± 0.11

0.028 ± 0.001

0.031 ± 0.001

65±4

69±5

All values were expressed as mean ± s.e.m. (n = 6–8 per litter/group). Body
weight was evaluated on a per litter basis. Pancreas weight and glycemia
were evaluated on two females and two males per litter. Significant
differences between treatment groups determined by one-way ANOVA
(P < 0.05).

diabetic rats receiving olive oil and diabetic rats given
vehicle (P < 0.05) (Fig. 1A), This was not seen in females
(Fig. 1C). However, at 5 months of age, the percentage of
islet area was significantly reduced (P < 0.05) in the male
offspring from diabetic rats compared to the control group
and significantly increased to control values (P < 0.05)
Table 3

Q9

Weight and glycemia in 5-month old female and

male offspring.

Females
Body weight (g)
Pancreas
weight(g)
Glycemia (mg/
dL)
Males
Body weight (g)
Pancreas
weight(g)
Glycemia (mg/
dL)

Control

Maternal
diabetes

Maternal
diabetes + olive
oil

383 ± 15
1.03 ± 0.10

421 ± 11
0.88 ± 0.062

380 ± 17
0.83 ± 0.07

133 ± 6b

140 ± 9b *

460 ± 18
0.99 ± 0.09

499 ± 5
0.97 ± 0.06

512 ± 17
0.92 ± 0.02

102 ± 12a

147 ± 11b

120 ± 12ab

104 ± 6a

All values were expressed as mean ± s.e.m. (n = 6–8 litters/group). Body
weight was determined on a per adjusted-litter basis. Pancreas weight
and glycemia were evaluated in two females and two males per litter.
Significant differences between treatment groups determined by one-way
ANOVA. Different letters represent means that are significantly different
from one another according to Bonferroni post-hoc test (P < 0.05).

Q8
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Figure 1
Representation of the percentage of islets in total pancreas area in
offspring at day 2 and 5 months of age: Graphs A (males) and C (females)
represents day 2 and graphs B (males) and D (females) 5 months of age.
Bars represent control animals (white), diabetic animals (grey) and
diabetic treated with olive oil (black). All values were expressed as
mean ± s.e.m. (n = 6–8 animals/group). Significant differences between
treatment groups were determined by one-way ANOVA. Different letters
represent means that are significantly different from one another
according to Bonferroni post-hoc test (P < 0.05).

Q10

Q11

Q12

Olive oil in pregnancy impacts
β-cell development

in the male offspring of diabetic mothers that received
the olive-oil-supplemented diet (Fig. 1B). No differences
between groups were seen in the females at the same age
(Fig. 1D).
In addition, there was a significant decrease of
the β-cell mass in the male offspring from diabetic rats
(P < 0.01) that was prevented by the dietary maternal
treatment with olive oil (Fig. 2B). Females at the same
age did not exhibit any differences between experimental
treatments with respect to β-cell mass (Fig. 2D). In view of
these results and given females did not demonstrate any
differences in the islet architecture in postnatal life, we
decided to focus further analysis only in males.
Islet number and size distribution in males at 5 months
of age was examined and the number of small (5000–
10,000 µm2) and large (>10,000 µm2) in the offspring of
diabetic rats supplemented with olive oil was significantly
increased (P < 0.05) compared to the offspring of both
control and diabetic rats fed the standard chow diet (Fig.
3). Total number of islets was also increased in the adult
offspring of diabetic rats fed with the diet supplemented
with olive oil compared to the diabetic group that did
not receive the olive oil (P < 0.001) (Fig. 3). At this age,
there was a significant increase in islets clusters (2–3 cells)
budding near pancreatic ducts (most of them β-cell origin)
(Fig. 4A) of diabetic rats fed the olive-oil-supplemented
diet compared to the diabetic group (P < 0.01). However,
https://joe.bioscientifica.com
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Figure 2
Representation of the total β-cell mass in offspring pancreata at day 2 and
5 months of age: Graphs A (males) and C (females) day 2 and graphs B
(males) and D (females) 5 months of age. Bars represent control animals
(white), diabetic animals (grey) and diabetic treated with olive oil (black).
All values were expressed as mean ± s.e.m. (n = 6–8 animals/group).
Significant differences between treatment groups were determined by
one-way ANOVA. Different letters represent means that are significantly
different from one another according to Bonferroni post-hoc test
(P < 0.05).

no changes in α-cell clusters were observed between the
groups (Fig. 4B).
Effects of maternal olive-oil supplementation on
pancreatic PPAR expression and their distribution
within the endocrine pancreas in the offspring
Real-time quantitative PCR was employed to assess the
effects of olive-oil supplementation during pregnancy
on postnatal pancreatic PPAR gene expression. No
differential expression on the steady-state levels
of PPARα was seen at 5 months of age (Fig. 6A). By
immunofluorescence, PPARα was localized to the mantle
of the islet (α cell area) suggesting co-localization with
glucagon secreting cells (Fig. 5A). However, pancreatic
PPAR β/δ expression was significantly reduced (P < 0.01) in
the adult offspring of diabetic rats compared to controls
but was restored in the offspring of diabetic rats that
received olive oil as a supplement during pregnancy
(Fig. 6B). By immunofluorescence, PPAR β/δ was also
localized at the mantle of the islet (to the cytoplasm
of α cells) and the nuclei of β-cells (Fig. 5B) suggesting
some role in β-cell differentiation or function. Finally,
PPARγ was significantly reduced (P < 0.05) in the pancreas
of the offspring of diabetic rats regardless of olive-oil
supplementation (Fig. 6C). Moreover, PPARγ was also
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Figure 3
Representative microphotographs of large (A), medium (B) and small islets (C). Arrows indicate β cells (red) and α cells (brown). Column graphs represent
the distribution of islets by size within the different treatments from male 5-month-old rats. Bars represent control animals (white), diabetic animals
(grey) and diabetic treated with olive oil (black). All values were expressed as mean ± s.e.m. (n = 6–8 animals/group). Significant differences between
treatment groups were determined by one-way ANOVA. Different letters represent means that are significantly different from one another according to
Bonferroni post-hoc test (P < 0.05).

localized in the area where α cells are present in the rat
islets by dual immunofluorescence (Fig. 5C).
Examining the direct effects of oleic acid on
pancreatic PPAR expression

Figure 4
Representative microphotograph of beta cell clusters near ducts. The
arrows identify insulin secreting β cells. On the right-hand side, graphs
represent the number of β, α and total clusters per total pancreas area in
male offspring at 5 months of age. Bars represent control animals (white),
diabetic animals (grey) and diabetic treated with olive oil (black). All values
were expressed as mean ± s.e.m. (n = 6–8 animals/group). Significant
differences between treatment groups were determined by one-way
ANOVA. Different letters represent means that are significantly different
from one another according to Bonferroni post-hoc test (P < 0.05).
https://joe.bioscientifica.com
https://doi.org/10.1530/JOE-20-0047
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When both cell lines were treated with oleic acid for 24
h, INS-1E cells showed a differential profile of PPAR gene
expression compared to αTC1–6 cells. Treatment with OA
reduced gene expression of PPAR-α (~20%) and PPAR-γ
(~96%) and increased gene expression of PPAR-β/δ (~20%)
compared to corresponding controls in INS-1E cells.
Meanwhile in αTC1–6, OA increased the gene expression
of PPAR-α, PPAR-β/δ and PPAR-γ mRNA around ~310%,
~260%, and ~410 %, respectively, compared to controls.
These results show for the first time that PPAR expression
can be induced also in α-cells. Mainly, in this case, oleic
acid significantly increased the gene expression of PPAR-α
(P < 0.01), PPAR-β/δ (P < 0.05) and PPAR-γ (P < 0.01) in
αTC1–6 cells compared to INS-1E cells (Fig. 7A).
In order to confirm if these differences seen in INS-1E
cells and αTC1–6 cells occur in the presence of other PPAR
natural agonists, we tested and compared LTB4, CPC and
15dPGJ2. LTB4, a PPAR-α agonist, significantly increased
mRNA expression of all PPARs in α cells compared to β
cells with different levels of significance (Fig. 7B) (P < 0.01),
(P < 0.05), (P < 0.05), respectively. Also, CPC, a PPAR-β/δ
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Figure 5
Representative microphotographs of PPARα, PPAR β/δ and γ. (A) Arrows identify PPARα (red) and insulin (green). (B) Arrows identify PPARβ/δ (red) in the
nucleus of β-cells and insulin (green). (C) Arrows identify PPARγ (red) and insulin (green).
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agonist, did not have any effect on any of the PPARs
in INS-1E cells. Although, in αTC1–6, cells significantly
increased the expression of PPAR-α (~297%) and PPAR-γ
(279%) (Fig. 7C). Meanwhile, 15dPGJ2 (PPAR-γ agonist)
increased the expression of PPAR-γ mRNA in INS-1E cells
(~191%) with no effect on αTC1–6. However, 15dPGJ2
significantly increased PPAR-β/δ gene expression (~127%)
in αTC1–6 cells (Fig. 7D). These results imply that PPARs
can be induced in either α- or β cells and that their
expression depends on the stimulus.
Interestingly, when PPARs downstream target genes
such as Pdx-1 and insulin were measured after OA,
15dPGJ2 and LTB4 treatments in INS-1E cells, both were

Figure 6
Expression of PPARα (A), PPAR β/δ (B) and PPARγ (C) by q-PCR. Bars
represent control animals (white), diabetic animals (grey) and diabetic
treated with olive oil (black). *P < (0.05) and ***P < 0.001. All values were
expressed as mean ± s.e.m. (n = 6–8 animals/group). Significant differences
between treatment groups were determined by one-way ANOVA.
Different letters represent means that are significantly different from one
another according to Bonferroni post-hoc test (P < 0.05).
https://joe.bioscientifica.com
https://doi.org/10.1530/JOE-20-0047
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significantly increased, while treatment with CPC had no
effect (Fig. 8).
Discussion
Population studies had shown that dietary habits resulting
high in monounsaturated fatty acids (MUFAs) attributed
to olive-oil consumption leads to overall reduced
inflammatory markers and better health outcomes
(Jiménez-Gómez et al. 2009, Schwingshackl & Hoffmann

Figure 7
INS-1E cells and αTC1-6 cells treated with oleic acid (OA; 5 μM), leukotriene
B4 (LTB4; 0.1 μM), 15 deoxy prostaglandin J2 (15dPGJ2; 1 μM), and
carbaprostacyclin (CPC; 1 μM) for 24 h. Gene expression levels of PPAR-α,
PPAR-β/δ and PPAR-γ were determined following treatment with (A) OA,
(B) LTB4 (C) 15dPGJ2, and (D) CPC using qRT-PCR. Levels of PPAR-α,
PPAR-β/δ and PPAR-γ were normalized to an internal control, β-Actin. The
normalized levels of transcripts were shown as relative percent to that of
non-treated control. t-test analysis (α = 0.05) was performed to compare
the levels of difference between αTC1-6 cells and INS-1E cells for each
gene. *P < (0.05); **P < 0.01; ***P < 0.001.
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Figure 8
mRNA expression levels of (A) insulin and (B) Pdx-1 after treatment of
INS-1E cells and αTC1-6 cells with OA, PGJ2, LTB4 and CPC determined by
qRT-PCR. Log2 fold changes were calculated compared to the respective
controls.

2014). Moreover, oleic acid, the major component of olive
oil, reduces LDL and total cholesterol levels with beneficial
consequences on blood sugar control and reducing insulin
resistance, culminating in a better management of type 2
diabetes (T2D). Oleic acid also reverses inflammation in
obesity (Ryan 2000). Aside from regulating glycemia in
adulthood, olive oil is promising during development as
well (Jawerbaum & Capobianco 2011).
Previously, we have shown that daily dietary oliveoil supplementation administered to mildly diabetic
rats during pregnancy improved the development of
the placenta and fetus with beneficial effects in different
organs, including the heart and the lung (Kurtz et al.
2014a,b, Capobianco et al. 2008). The benefit to these
organs has been attributed to PPARs activation and
restoration of PPAR levels (Capobianco et al. 2008b,
2015, Kurtz et al. 2014a). Specifically, these PPARs have
anti-inflammatory functions and their expression is
https://joe.bioscientifica.com
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reduced in the placenta from diabetic rats and from pregestational and gestational diabetic patients (Capobianco
et al. 2005, 2013, Martínez et al. 2008, 2011, Wieser et al.
2008, Arck et al. 2010, Holdsworth-Carson et al. 2010)
Moreover, impaired PPAR pathways and levels of PPARs
endogenous ligands in the placenta are rescued with
olive-oil supplementation (Capobianco et al. 2008a).
Besides, we previously found that maternal olive-oil
supplementation increases insulin levels and decreases
triglycerides in the 5-month-old offspring from diabetic
rats (Capobianco et al. 2015). The proposed dietary
supplementation provides half of the calories from lipids
derived from olive oil, and thus, it would be feasible to be
recommended in humans, as it corresponds to three daily
spoons of olive oil. Therefore, we proposed that maternal
dietary manipulations (such as the addition of olive oil)
may add to the benefits of the tight insulin monitoring
to mothers with pre-gestational or gestational diabetes on
the development of the pancreata in postnatal life.
In rodents, the pancreas and other metabolic organs
are not fully developed at birth. During e-18.5 to e-20.5,
β-cells duplicate in number (Kaung 1994). Any alterations
in this period are of importance as it determines the health
or predisposition to develop disease of the individual
long-term. By weaning, the quantity and quality of β cells
are finally defined (Kaung 1994, Petrik et al. 1999, Zhang
et al. 2005). Tight regulation of β-cell mass is required for
preserving insulin secretion capacity over a life time.
In this study, by postnatal day 2, no significant
differences were observed between treatments and sexes
with respect to β-cell mass (mg), suggesting that at this
time point the effects of maternal status of disease or
diet had not manifested. However, by 5 months of age,
males of diabetic mothers were overtly glucose intolerant
(Capobianco et al. 2015) and exhibited reduced β-cell
mass. Interestingly, maternal olive-oil supplementation
prevented fasting hyperglycemia in the male offspring due,
in part, to prevention of β-cell mass and total pancreatic
islet loss. The benefits of olive-oil supplementation in
these offspring could also be attributed to higher number
of larger islets and clusters near the ducts (mainly β-cells).
Nevertheless, the increased β-cell number observed
does not always account for hyperinsulinemia and
hypoglycaemia (Zhang et al. 2005) or changes in plasma
insulin levels (Nguyen et al. 2006). Given females did not
show any glycemic differences within treatments at either
developmental age, further studies were only conducted
in males.
Previous studies have demonstrated that, during
development, PPAR α, β/δ and γ are ubiquitously
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distributed in the pancreas and play essential roles in the
regulation of its cellular differentiation, proliferation and
metabolism (Braissant et al. 1996). During late gestation
(i.e. gestational day 18.5), PPARα is expressed in the
pancreas during a period when cells adapt from high-fat
oxidation to high-glucose oxidation (Gremlich et al. 2005).
Deletion of PPARα in ob/ob mice developed pancreatic
β-cell dysfunction characterized by reduced mean islet
area and decreased insulin secretion in response to glucose
in vitro and in vivo (Lalloyer et al. 2006). Although PPAR
isoforms are expressed in islets (Braissant et al. 1996), their
function is still unclear.
In the adult rat pancreas, they are expressed in both
the exocrine and the endocrine pancreas and by in situ
hybridization and gene expression analysis PPARα and
have lower expression when compared with PPARβ/δ
(Braissant et al. 1996). PPARβ/δ is highly expressed in β-cells
(Iglesias et al. 2012). Furthermore, in the diabetic male
offspring at 5 months of age, the expression of PPARβ/δ
was reduced significantly but restored to control levels in
the offspring of diabetic mothers treated with olive oil.
In this group, PPARβ/δ was found in the nucleus of β cells
suggesting that may be involved in β-cell differentiation
and proliferation as observed histologically. Under normal
cell culture conditions, we further determined that the
steady-state levels of PPARβ/δ mRNA were increased in
both INS1-E and αTC1–6 cells. Activation of PPARβ/δ by its
ligands increases fatty acid oxidation capacity in INS-1E
cells, enhances glucose stimulated insulin secretion
(GSIS) in islets and protects GSIS against the effects of
prolonged fatty acid exposure (Cohen et al. 2011). In
db/db mice, prolonged treatment with PPARβ/δ agonists
(GW501516) reduced blood glucose by improving insulin
sensitivity and islet function (Yang et al. 2016). A recent
report indicates that a pharmacological ligand of PPARβ/δ
amplifies the adaptive insulin secretory response of β-cells
upon exposure to increasing concentrations of glucose in
both INS-1E and rat isolated islets (Winzell et al. 2010).
Others suggested that PPARβ/δ is a master regulator of
functions associated with each step of insulin secretion
(granule biosynthesis, vesicle trafficking and exocytosis)
and may have a repressive role controlling β-cell mass and
insulin exocytosis (Hellemans et al. 2007) with a protective
effect against metabolic stress in β-cells (Ravnskjaer et al.
2010).
Taking into consideration all the observations listed
previously, we suggest that PPARβ/δ may have had a role in
restoring the β-cell mass in the male offspring of diabetic
rats that received the olive-oil supplementation during
pregnancy. In contrast, PPARα gene expression did not
https://joe.bioscientifica.com
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differ between treatment groups at 5 months of age, and it
was only localized in the cytoplasm of α cells, suggesting
that it has minimal effects on β-cell gene expression in
adulthood. Furthermore, PPARα mRNA was also increased
in αTC1–6 cells after OA exposure. Finally, we examined
the expression of PPARγ and our studies showed a reduced
expression of PPARγ in the 5-month pancreas of the
offspring of diabetic rats, which was not prevented by
the maternal treatment with olive oil, and that this PPAR
isotype was only localized in α cells. While it has been
shown that PPARγ is localized in both β cells (Braissant
et al. 1996) and in α cells (Laybutt et al. 2002, Gupta et al.
2008), we were only able to detect its localization in α cells.
This PPAR isotype has been previously demonstrated to
represses glucagon transcription in the islets (Rosen et al.
2003) and its signaling is implicated in the regulation of
β-cell proliferation in adults. Mice with deleted expression
of PPARγ in β-cell had significant islet hyperplasia but,
despite this alteration in β-cell mass, no effect on glucose
homeostasis was noted (Rosen et al. 2003, Moibi et al.
2007). Another study showed that PPARγ may regulate
Pdx-1 transcription (Kim et al. 2002, Gupta et al. 2008),
glucokinase (Kim et al. 2000), glucose transporter (Glut2)
(Gupta et al. 2008) and indirectly β-cell function and mass
(Laybutt et al. 2002). In our hands, the in vitro experiments
showed that exposure with OA increased PPAR γ mRNA
only in αTC1–6 cells where it could be acting as a repressor.
In order to elucidate if the in vitro effects of OA was
specific, we tested both cell lines with three different natural
PPAR agonists and found that they were differentially
expressed in both cell lines. To this end, the expression of
PPARs did not show a common characteristic among all
three isotypes of PPARs in β cells. However, aside of OA,
all administered agonists dramatically reduced PPARβ/δ
expression in β-cells. Although, PPARs downstream
target genes such as PDX-1 and insulin were significantly
increased in (INS-1E cells) after OA, 15dPGJ2 and LTB4
treatments.
Another important point to address from these results
is the novelty that both OA and LTB4 increased the
expression levels for all three isotypes of PPARs in αTC1–6
cells. However, such pattern was not shown in INS-1E
cells, suggesting that OA has a differential effect in α cell
compared to β cell in vitro.
In summary, this study has identified the distribution
and the expression of PPARs in different cell populations
within the endocrine pancreas when maternally exposed
to a diet enriched in oleic acid. We also demonstrated
histologically that PPARβ/δ is present in the β cells at
5 months postnatal, while PPAR α and γ are only in α
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cells suggesting a different role of these PPARs in the
adult endocrine pancreas. To elucidate the underlying
mechanisms, we also examined the direct effects of oleic
acid in α- and β-cell lines and found that all PPARs were
differentially expressed in both cell lines. More so, all PPAR
isoforms were present in αTC1–6 cells when stimulated
by oleic acid. The up-regulated gene expression of all
three PPARs in αTC1–6 suggests a role for these nuclear
receptors in a counter regulatory mechanism between α
and β cells which are likely important for the maintenance
of β-cell survival and function. Furthermore, we showed
for the first time to our knowledge in vivo and in vitro
the presence of PPARs in α cells. Collectively, based on
these observations, we suggest that, in male offspring of
mildly diabetic mothers, the early exposure of 6% olive
oil may have permitted a normal pancreas development,
likely due to the indirect effect of the maternal diet
(e.g. oleic acid) on the intrauterine micro-environment
(Capobianco et al. 2018) or by a direct effect by the
activation of PPARs during fetal pancreatic development.
Both interactions may have programmed β cells in utero
and rescued male offspring from an early onset of T2D in
adulthood.
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